{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:40:05Z","timestamp":1782474005121,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00432-022-04264-y","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T10:03:03Z","timestamp":1661853783000},"page":"3215-3223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Application of real-time MRI-guided linear accelerator in stereotactic ablative body radiotherapy for non-small cell lung cancer: one step forward to precise targeting"],"prefix":"10.1007","volume":"148","author":[{"given":"Hye Jin","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo-Kang","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myungsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"4264_CR1","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1200\/JCO.2008.21.5681","volume":"27","author":"P Baumann","year":"2009","unstructured":"Baumann P, Nyman J, Hoyer M et al (2009) Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 27:3290\u20133296. https:\/\/doi.org\/10.1200\/JCO.2008.21.5681","journal-title":"J Clin Oncol"},{"key":"4264_CR2","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1002\/mp.12227","volume":"44","author":"ED Brandner","year":"2017","unstructured":"Brandner ED, Chetty IJ, Giaddui TG, Xiao Y, Huq MS (2017) Motion management strategies and technical issues associated with stereotactic body radiotherapy of thoracic and upper abdominal tumors: a review from NRG oncology. Med Phys 44:2595\u20132612. https:\/\/doi.org\/10.1002\/mp.12227","journal-title":"Med Phys"},{"key":"4264_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.radonc.2017.05.016","volume":"124","author":"S Ehrbar","year":"2017","unstructured":"Ehrbar S, Johl A, Tartas A et al (2017) ITV, mid-ventilation, gating or couch tracking - a comparison of respiratory motion-management techniques based on 4D dose calculations. Radiother Oncol 124:80\u201388. https:\/\/doi.org\/10.1016\/j.radonc.2017.05.016","journal-title":"Radiother Oncol"},{"key":"4264_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/519602","volume":"2013","author":"P Giraud","year":"2013","unstructured":"Giraud P, Houle A (2013) Respiratory gating for radiotherapy: main technical aspects and clinical benefits. ISRN Pulmonology 2013:519602. https:\/\/doi.org\/10.1155\/2013\/519602","journal-title":"ISRN Pulmonology"},{"key":"4264_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/s0360-3016(99)00154-6","volume":"45","author":"J Hanley","year":"1999","unstructured":"Hanley J, Debois MM, Mah D et al (1999) Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. Int J Radiat Oncol Biol Phys 45:603\u2013611. https:\/\/doi.org\/10.1016\/s0360-3016(99)00154-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4264_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/cncr.22763","volume":"110","author":"H Hof","year":"2007","unstructured":"Hof H, Muenter M, Oetzel D, Hoess A, Debus J, Herfarth K (2007) Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer 110:148\u2013155. https:\/\/doi.org\/10.1002\/cncr.22763","journal-title":"Cancer"},{"key":"4264_CR7","doi-asserted-by":"publisher","first-page":"e278S","DOI":"10.1378\/chest.12-2359","volume":"143","author":"JA Howington","year":"2013","unstructured":"Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC (2013) Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 143:e278S-e313S. https:\/\/doi.org\/10.1378\/chest.12-2359","journal-title":"Chest"},{"key":"4264_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13014-016-0699-2","volume":"11","author":"J Kim","year":"2016","unstructured":"Kim J, Wu Q, Zhao B, Wen N, Ajlouni M, Movsas B, Chetty IJ (2016) To gate or not to gate - dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer. Radiat Oncol 11:125. https:\/\/doi.org\/10.1186\/s13014-016-0699-2","journal-title":"Radiat Oncol"},{"key":"4264_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.radonc.2007.10.017","volume":"85","author":"M Koto","year":"2007","unstructured":"Koto M, Takai Y, Ogawa Y et al (2007) A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 85:429\u2013434. https:\/\/doi.org\/10.1016\/j.radonc.2007.10.017","journal-title":"Radiother Oncol"},{"key":"4264_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ijrobp.2019.03.045","volume":"110","author":"P Lee","year":"2021","unstructured":"Lee P, Loo BW Jr, Biswas T et al (2021) Local control after stereotactic body radiation therapy for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 110:160\u2013171. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.03.045","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4264_CR11","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1016\/j.ijrobp.2012.01.018","volume":"83","author":"Y Matsuo","year":"2012","unstructured":"Matsuo Y, Shibuya K, Nakamura M et al (2012) Dose\u2013volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 83:e545-549. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.01.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4264_CR12","doi-asserted-by":"publisher","first-page":"S2437","DOI":"10.21037\/jtd.2018.01.155","volume":"10","author":"JK Molitoris","year":"2018","unstructured":"Molitoris JK, Diwanji T, Snider JW 3rd et al (2018) Advances in the use of motion management and image guidance in radiation therapy treatment for lung cancer. J Thorac Dis 10:S2437\u2013S2450. https:\/\/doi.org\/10.21037\/jtd.2018.01.155","journal-title":"J Thorac Dis"},{"key":"4264_CR13","doi-asserted-by":"publisher","first-page":"20160732","DOI":"10.1259\/bjr.20160732","volume":"90","author":"P Murray","year":"2017","unstructured":"Murray P, Franks K, Hanna GG (2017) A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer. Br J Radiol 90:20160732. https:\/\/doi.org\/10.1259\/bjr.20160732","journal-title":"Br J Radiol"},{"key":"4264_CR14","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.ijrobp.2005.05.034","volume":"63","author":"Y Nagata","year":"2005","unstructured":"Nagata Y, Takayama K, Matsuo Y et al (2005) Clinical outcomes of a phase I\/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63:1427\u20131431. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.05.034","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4264_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.radonc.2012.10.016","volume":"106","author":"HD Nissen","year":"2013","unstructured":"Nissen HD, Appelt AL (2013) Improved heart, lung and target dose with deep inspiration breath hold in a large clinical series of breast cancer patients. Radiother Oncol 106:28\u201332. https:\/\/doi.org\/10.1016\/j.radonc.2012.10.016","journal-title":"Radiother Oncol"},{"key":"4264_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13014-019-1293-1","volume":"14","author":"M Oechsner","year":"2019","unstructured":"Oechsner M, Dusberg M, Borm KJ, Combs SE, Wilkens JJ, Duma MN (2019) Deep inspiration breath-hold for left-sided breast irradiation: analysis of dose-mass histograms and the impact of lung expansion. Radiat Oncol 14:109. https:\/\/doi.org\/10.1186\/s13014-019-1293-1","journal-title":"Radiat Oncol"},{"key":"4264_CR17","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1097\/JTO.0b013e318074de34","volume":"2","author":"H Onishi","year":"2007","unstructured":"Onishi H, Shirato H, Nagata Y et al (2007) Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2:S94-100. https:\/\/doi.org\/10.1097\/JTO.0b013e318074de34","journal-title":"J Thorac Oncol"},{"key":"4264_CR18","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/s0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma DA, Olson R, Harrow S et al (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 393:2051\u20132058. https:\/\/doi.org\/10.1016\/s0140-6736(18)32487-5","journal-title":"Lancet"},{"key":"4264_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.annonc.2019.10.026","volume":"31","author":"K Park","year":"2020","unstructured":"Park K, Vansteenkiste J, Lee KH et al (2020) Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS. Ann Oncol 31:191\u2013201. https:\/\/doi.org\/10.1016\/j.annonc.2019.10.026","journal-title":"Ann Oncol"},{"key":"4264_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.rpor.2018.11.003","volume":"24","author":"J Prunaretty","year":"2019","unstructured":"Prunaretty J, Boisselier P, Ailleres N et al (2019) Tracking, gating, free-breathing, which technique to use for lung stereotactic treatments? A dosimetric comparison. Rep Pract Oncol Radiother 24:97\u2013104. https:\/\/doi.org\/10.1016\/j.rpor.2018.11.003","journal-title":"Rep Pract Oncol Radiother"},{"key":"4264_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/s0360-3016(02)04143-3","volume":"55","author":"VM Remouchamps","year":"2003","unstructured":"Remouchamps VM, Vicini FA, Sharpe MB, Kestin LL, Martinez AA, Wong JW (2003) Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys 55:392\u2013406. https:\/\/doi.org\/10.1016\/s0360-3016(02)04143-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4264_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/485067","volume":"2014","author":"A Sawant","year":"2014","unstructured":"Sawant A, Keall P, Pauly KB et al (2014) Investigating the feasibility of rapid MRI for image-guided motion management in lung cancer radiotherapy. Biomed Res Int 2014:485067. https:\/\/doi.org\/10.1155\/2014\/485067","journal-title":"Biomed Res Int"},{"key":"4264_CR23","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/jto.0000000000000525","volume":"10","author":"Y Shibamoto","year":"2015","unstructured":"Shibamoto Y, Hashizume C, Baba F et al (2015) Stereotactic body radiotherapy using a radiobiology-based regimen for stage I non-small-cell lung cancer: five-year mature results. J Thorac Oncol 10:960\u2013964. https:\/\/doi.org\/10.1097\/jto.0000000000000525","journal-title":"J Thorac Oncol"},{"key":"4264_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1053\/j.seminoncol.2018.06.002","volume":"45","author":"A Shinde","year":"2018","unstructured":"Shinde A, Li R, Kim J, Salgia R, Hurria A, Amini A (2018) Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly. Semin Oncol 45:210\u2013219. https:\/\/doi.org\/10.1053\/j.seminoncol.2018.06.002","journal-title":"Semin Oncol"},{"key":"4264_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1349-7006.2011.02114.x","volume":"103","author":"H Shirato","year":"2012","unstructured":"Shirato H, Onimaru R, Ishikawa M et al (2012) Real-time 4-D radiotherapy for lung cancer. Cancer Sci 103:1\u20136. https:\/\/doi.org\/10.1111\/j.1349-7006.2011.02114.x","journal-title":"Cancer Sci"},{"key":"4264_CR26","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1097\/jto.0000000000000317","volume":"9","author":"DB Shultz","year":"2014","unstructured":"Shultz DB, Filippi AR, Thariat J, Mornex F, Loo BW Jr, Ricardi U (2014) Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer. J Thorac Oncol 9:1426\u20131433. https:\/\/doi.org\/10.1097\/jto.0000000000000317","journal-title":"J Thorac Oncol"},{"key":"4264_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00066-017-1194-x","volume":"194","author":"S Temming","year":"2018","unstructured":"Temming S, Kocher M, Stoelben E et al (2018) Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer. Strahlenther Onkol 194:91\u201397. https:\/\/doi.org\/10.1007\/s00066-017-1194-x","journal-title":"Strahlenther Onkol"},{"key":"4264_CR28","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1001\/jamaoncol.2018.1251","volume":"4","author":"RD Timmerman","year":"2018","unstructured":"Timmerman RD, Paulus R, Pass HI et al (2018) Stereotactic body radiation therapy for operable early-stage lung cancer: findings from the NRG oncology RTOG 0618 trial. JAMA Oncol 4:1263\u20131266. https:\/\/doi.org\/10.1001\/jamaoncol.2018.1251","journal-title":"JAMA Oncol"},{"key":"4264_CR29","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.ijrobp.2018.11.051","volume":"103","author":"GM Videtic","year":"2019","unstructured":"Videtic GM, Paulus R, Singh AK et al (2019) Long-term follow-up on NRG oncology RTOG 0915 (NCCTG N0927): a randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer. Int J Radiat Oncol Biol Phys 103:1077\u20131084. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.11.051","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4264_CR30","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1177\/1533034617691407","volume":"16","author":"AP Wojcieszynski","year":"2017","unstructured":"Wojcieszynski AP, Hill PM, Rosenberg SA et al (2017) Dosimetric comparison of real-time MRI-guided tri-cobalt-60 versus linear accelerator-based stereotactic body radiation therapy lung cancer plans. Technol Cancer Res Treat 16:366\u2013372. https:\/\/doi.org\/10.1177\/1533034617691407","journal-title":"Technol Cancer Res Treat"},{"key":"4264_CR31","doi-asserted-by":"publisher","first-page":"16203","DOI":"10.1038\/s41598-020-73240-8","volume":"10","author":"Y Yamada","year":"2020","unstructured":"Yamada Y, Yamada M, Chubachi S et al (2020) Comparison of inspiratory and expiratory lung and lobe volumes among supine, standing, and sitting positions using conventional and upright CT. Sci Rep 10:16203. https:\/\/doi.org\/10.1038\/s41598-020-73240-8","journal-title":"Sci Rep"},{"key":"4264_CR32","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.ijrobp.2016.03.024","volume":"95","author":"J Zhao","year":"2016","unstructured":"Zhao J, Yorke ED, Li L et al (2016) Simple factors associated with radiation-induced lung toxicity after stereotactic body radiation therapy of the thorax: a pooled analysis of 88 studies. Int J Radiat Oncol Biol Phys 95:1357\u20131366. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.03.024","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04264-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-04264-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04264-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T11:37:51Z","timestamp":1663933071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-04264-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["4264"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-04264-y","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]},"assertion":[{"value":"9 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the institutional review board of the Catholic Medical Center ethics committee (IRB No. OC22RISI0014).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"As a retrospective study using medical records that do not contain patient's personal information, the consent process was exempted.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"As a retrospective study using medical records that do not contain patient's personal information, the consent process was exempted.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}